Neurogenetic Testing Market

Neurogenetic Testing Market - Global Assessment 2021 - 2031, Industry Analysis and Opportunity

Neurogenetic Testing Market Segmented By MRI, Next generation sequencing, Multiplex ligation-dependent probe amplification (MLPA) and Fragment analysis PCR Technique

Industry: Healthcare

Format: PPT*, PDF, EXCEL

Delivery Timelines: Contact Sales

Report Type: Ongoing

Report Price

$ 4900*

Pre Book
Request Report Sample

Report ID: PMRREP32899

Neurogenetic Testing Market Forecast and CAGR

According to the latest research by Persistence Market Research, the neurogenetic testing market is set to witness positive growth of CAGR 7% during 2021-2031. Any defect in one or more genes affecting the nervous system causes neurogenetic disorder.

These may include dementia, hereditary neuropathy, Parkinson disease, Epileptic disorders, etc. The Neurogenetic Testing market is majorly driven by advancements in DNA sequencing techniques and increasing research in the life science domain. These method provide an accurate course of treatment of the disorder.

What Is Driving Demand for Neurogenetic Testing?

The major drivers demand for neurogenetic testing are increasing prevalence of neurological diseases, awareness among common population about genetic screening, availability of modern diagnostic methods and increasing life science R&D. Various technological advancements are happening in DNA sequencing. Currently the method used for DNA sequencing is next-generation sequencing.

Another driver is the prevalence of various neurological disorders. According to a WHO report, the European region contribute 11.2% of global burden of neurological disorder followed by Western Pacific region with 10%. According to a report, the number of deaths caused by neurological disorder is increased by 39% in the past 30 years.

This increase in the prevalence therefore acts as a driven for neurological testing market. An increase in the awareness about treatments and R & D investment by the companies for developing new techniques and acquiring other companies is expected to increase demand for neurogenetic testing during the forecast period.

Impact of COVID on Neurogenetic Testing Market

COVID-19 had an impact on the neurogenetic testing market. The funds from the government increased during this time for research. But these funds were utilized for researching Sars Cov 2 genomics. This impacted the screening and many early signs of neurological disorders went undetected.

During this pandemic times, the hospitals started giving neurogenetics counselling through telephone videoconferencing (telegenetics) for remote places. However, this pandemic has allowed researchers to come up with new techniques for neurogenetic testing. The market had an overall negative impact due to COVID-19.

Who Are The Key Manufacturers Of Neurogenetic Testing?

Some of the leading manufacturers of neurogenetic testing include

  • Neurogene Inc.
  • Pacific Biosciences of California Inc.
  • Victorian Clinical Genetics Services
  • MedGenome
  • Blueprint Genetics Oy
  • Laboratory Corporation of America.

Regional Outlook Of Neurogenetic Testing Market

The region that is dominating the neurogenetics testing market is North America with countries like the US and Canada. These countries have increased their healthcare spending and has the presence of major players. Also, advancements in DNA sequencing techniques, increase in research funding by the government are driving factors for the market.

Followed by North America, the region that is expected to dominate the market is Asia. This is because of increase in prevalence of neurological disorders in this region. According to a report, the prevalence of neurological disorders are higher in low and middle income countries. Apart from this, the advancements in the DNA sequencing technique and an increase in life science research are driving the market.

Key Segments

By Technique

  • MRI
  • Next generation sequencing
  • Multiplex ligation-dependent probe amplification (MLPA)
  • Fragment analysis PCR

By End-user

  • Hospitals
  • Specialty clinics
  • Research institutes
  • Diagnostics laboratories

By Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Neurogenetic Testing Market Report Highlights:

  • Detailed overview of the parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprints

NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.

To know more about delivery timeline for this report Contact Sales

Companies Covered in This Report

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate